Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-11-15

Clinical Trial Update: Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy

View source ↗

Summary

Clinical trial investigating the role of the c242T polymorphism of p22phox in diabetic nephropathy among individuals with Type 1 diabetes; the study status is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Type 1 Diabetes Mellitus, Diabetic Nephropathy | Status: COMPLETED